EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns

Collin A Melton, Peter Freese, Yifan Zhou, Archana Shenoy, Siddhartha Bagaria iD, Christopher Chang iD, Chih-Chung Kuo, Eric Scott iD, Subashini Srinivasan, Gordon Cann, Manami Roychowdhury-Saha iD, Pei-Yun Chang und 1 weitere

Cancers · 23.12.2023 · 16 (1) · 82

DOI: 10.3390/cancers16010082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 23.12.2023. Verfasst von Collin A Melton und 12 weiteren Autor:innen. Beteiligte Einrichtung: GRAIL, LLC, Menlo Park, CA 94025, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grail (United States), GRAIL, LLC, Menlo Park, CA, USA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estimating the abundance of cell-free DNA (cfDNA) fragments shed from a tumor (i.e., circulating tumor DNA (ctDNA)) can approximate tumor burden, which has numerous clinical applications. We derived a novel, broadly applicable statistical method to quantify cancer-indicative methylation patterns within cfDNA to estimate ctDNA abundance, even at low levels. Our algorithm identified differentially methylated regions (DMRs) between a reference database of cancer tissue biopsy samples and cfDNA from individuals without cancer. Then, without utilizing matched tissue biopsy, counts of fragments matching the cancer-indicative hyper/hypo-methylated patterns within DMRs were used to determine a tumor methylated fraction (TMeF; a methylation-based quantification of the circulating tumor allele fraction and estimate of ctDNA abundance) for plasma samples. TMeF and small variant allele fraction (SVAF) estimates of the same cancer plasma samples were correlated (Spearman’s correlation coefficient: 0.73), and synthetic dilutions to expected TMeF of 10−3 and 10−4 had estimated TMeF within two-fold for 95% and 77% of samples, respectively. TMeF increased with cancer stage and tumor size and inversely correlated with survival probability. Therefore, tumor-derived fragments in the cfDNA of patients with cancer can be leveraged to estimate ctDNA abundance without the need for a tumor biopsy, which may provide non-invasive clinical approximations of tumor burden.

Schlagwörter

Stichwörter der Autor:innen

DNA methylationbiomarkerscell-free DNAcirculating tumor DNAcomputational methodsliquid biopsymachine learning algorithmstumor fractionvariant allele fraction

Autor:innen und Institutionen

  • GRAIL, LLC, Menlo Park, CA 94025, USA.

ORCID-Profile: Siddhartha Bagaria, Christopher Chang, Eric Scott, Manami Roychowdhury-Saha

Förderung

  • Grail (United States)
  • GRAIL, LLC, Menlo Park, CA, USA

Zitieren

APA

Melton, C. A., Freese, P., Zhou, Y., Shenoy, A., Bagaria, S., Chang, C., Kuo, C. C., Scott, E., Srinivasan, S., Cann, G., Roychowdhury-Saha, M., Chang, P. Y., & Singh, A. H. (2023). A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns. Cancers, 16(1), 82. https://doi.org/10.3390/cancers16010082

Vancouver

Melton CA, Freese P, Zhou Y, Shenoy A, Bagaria S, Chang C, et al. A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns. Cancers. 2023;16(1):82. doi:10.3390/cancers16010082

BibTeX
@article{Melton2023,
  author = {Melton, Collin A and Freese, Peter and Zhou, Yifan and Shenoy, Archana and Bagaria, Siddhartha and Chang, Christopher and Kuo, Chih-Chung and Scott, Eric and Srinivasan, Subashini and Cann, Gordon and Roychowdhury-Saha, Manami and Chang, Pei-Yun and Singh, Amoolya H},
  title = {A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns},
  journal = {Cancers},
  year = {2023},
  volume = {16},
  number = {1},
  pages = {82},
  doi = {10.3390/cancers16010082}
}
Kostenlos starten →